ClinicalTrials.Veeva

Menu

Double Filtration Plasmapheresis (DFPP) and Lipid Metabolism

S

Shanghai Pudong Hospital

Status

Unknown

Conditions

DFPP and Platelet Function

Treatments

Device: DFPP

Study type

Interventional

Funder types

Other

Identifiers

NCT03491956
ShanghaiPudongH2

Details and patient eligibility

About

Little clinic trials showed that Double Filtration Plasmapheresis (DFPP) could improve lipid metabolism, however, whether DFPP can improve platelet function and recover Endothelial function is unknown. In this study, we try to confirm the hypothesis that DFPP can improve endothelial function in hyperlipidemia patients.

Enrollment

30 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. hyperlipidemia

Exclusion criteria

  1. Severe liver and kidney dysfunction
  2. Severe cardiopulmonary insufficiency
  3. tumor
  4. pregnancy

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

DFPP group
Other group
Description:
self contrast (before and after DFPP)
Treatment:
Device: DFPP

Trial contacts and locations

1

Loading...

Central trial contact

Huimin Jin, doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems